Overview

Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the effect of Concerta (Osmotic Release Oral System Extended Release Methylphenidate HCL, OROS MPH) and Strattera (Atomoxetine) on the laboratory and ecological executive function in children with attention deficit hyperactivity disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Peking University
Treatments:
Atomoxetine Hydrochloride
Methylphenidate